Pictet Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Buy
15,482
+2,347
+18% +$45.4K ﹤0.01% 1662
2025
Q4
$283K Hold
13,135
﹤0.01% 1741
2025
Q3
$253K Sell
13,135
-165,516
-93% -$2.95M ﹤0.01% 1749
2025
Q2
$3.06M Sell
178,651
-758,372
-81% -$32.4M ﹤0.01% 833
2025
Q1
$60.7M Sell
937,023
-109,002
-10% -$11.5M 0.07% 276
2024
Q4
$127M Sell
1,046,025
-4,986
-0.5% -$611K 0.14% 174
2024
Q3
$131M Buy
1,051,011
+93,793
+10% +$13M 0.14% 172
2024
Q2
$151M Sell
957,218
-301,318
-24% -$38.7M 0.17% 145
2024
Q1
$163M Buy
1,258,536
+166,934
+15% +$20.4M 0.18% 150
2023
Q4
$105M Buy
1,091,602
+126,658
+13% +$12.2M 0.12% 198
2023
Q3
$117M Buy
+964,944
New +$109M 0.14% 177

Other funds holding SRPT